These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 32968877)

  • 21. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
    Zhang B; Yang L; Wang X; Fu D
    Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
    Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
    Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
    Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
    Front Immunol; 2021; 12():659444. PubMed ID: 34040608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
    Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
    J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
    Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
    Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a prognostic signature for esophageal cancer based on nine immune related genes.
    Zhang Z; Chen C; Fang Y; Li S; Wang X; Sun L; Zhou G; Ye J
    BMC Cancer; 2021 Feb; 21(1):113. PubMed ID: 33541291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
    Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
    Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Ferroptosis-Related Gene Signature for Prognosis Prediction in Ewing Sarcoma.
    Zhao R; Li Z; Huang Y; Xiong C; Zhang C; Liang H; Xu J; Luo X
    Anal Cell Pathol (Amst); 2022; 2022():6711629. PubMed ID: 36050939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
    Lei S; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma.
    Chen ZY; Yang H; Bu J; Chen Q; Yang Z; Li H
    J Oncol; 2021; 2021():3578949. PubMed ID: 34925508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Immune-Related Genes of Patients With Ewing's Sarcoma.
    Zhou Y; Xu B; Wu S; Liu Y
    Front Genet; 2021; 12():669549. PubMed ID: 34122521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
    Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
    BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.